Who are Takeda Pharmaceutical Company Limited's main suppliers?

Takeda Pharmaceutical Company Limited (TAK) key suppliers include: THIRD-PARTY-CONTRACT-MANUFACTURERS. View the full supplier network at chainsifter.com/chain/TAK.

Who are Takeda Pharmaceutical Company Limited's major customers?

Takeda Pharmaceutical Company Limited (TAK) key customers include: Nektar Therapeutics, Nektar Therapeutics. View the full customer network at chainsifter.com/chain/TAK.

What sector is Takeda Pharmaceutical Company Limited in?

Takeda Pharmaceutical Company Limited (TAK) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

TAK Supply Chain: Takeda Pharmaceutical Company Limited Suppliers & Customers

1Suppliers

2Customers

1Debt Items

20Related Chains

Takeda Pharmaceutical Company Limited Suppliers

Ticker	Name	Confidence	Evidence
THIRD-PARTY-CONTRACT-MANUFACTURERS	THIRD-PARTY-CONTRACT-MANUFACTURERS	92%	We source certain other products from third-party contract manufacturers.

Takeda Pharmaceutical Company Limited Customers

Ticker	Name	Confidence	Evidence
NKTR	Nektar Therapeutics	95%	or (recombinant)), a treatment for hemophilia A (congenital factor VIII deficiency) for control and prevention of bleeding episodes, for perioperative management and routine prophylaxis to prevent or…
NKTR	Nektar Therapeutics	95%	Reciprocal relationship from NKTR graph: Reciprocal relationship from TAK graph: or (recombinant)), a treatment for hemophilia A (congenital factor VIII deficiency) for control and prevention of blee…

Takeda Pharmaceutical Company Limited Debt Obligations

Instrument	Description	Confidence	Evidence
TAK-DEBT	Debt stack $34.3B	90%	Market cache reports total debt of $34.3B.

Takeda Pharmaceutical Company Limited Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Takeda Pharmaceutical Company Limited.

Takeda Pharmaceutical Company Limited Ownership

Holder	Name	Confidence	Evidence
TAK-OWNER-FRAZIER-LIFE-SCIENCES-MANAGEMENT	Frazier Life Sciences Management, L.P.	90%	13F overlay lists Frazier Life Sciences Management, L.P. as top holder; 179 tracked holders.

Takeda Pharmaceutical Company Limited Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
ATRA	Atara Biotherapeutics, Inc.	100.00	2
TRIB	Trinity Biotech plc	100.00	2
EWTX	Edgewise Therapeutics, Inc.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
CLGN	CollPlant Biotechnologies Ltd.	100.00	2
BCAX	Bicara Therapeutics Inc.	100.00	2
ALC	Alcon Inc.	100.00	2
REGN	Regeneron Pharmaceuticals, Inc.	100.00	2
DAWN	Day One Biopharmaceuticals Inc	100.00	2
AXSM	Axsome Therapeutics, Inc.	100.00	2
AORT	Artivion, Inc.	100.00	2
AVBP	ArriVent BioPharma, Inc.	100.00	2
ANIK	Anika Therapeutics, Inc.	100.00	2
BNR	Burning Rock Biotech Limited	100.00	2
BNRG	Brenmiller Energy Ltd	100.00	2
CLYM	Climb Bio, Inc.	100.00	2
CSTE	Caesarstone Ltd.	100.00	2
BLLN	BillionToOne, Inc.	100.00	2
SNNUF	Smith & Nephew plc	100.00	2
ADGM	Adagio Medical Holdings, Inc.	100.00	2

Takeda Pharmaceutical Company Limited Supply Chain